A randomized prospective study investigating the optimum power settings for selective laser trabeculoplasty (SLT) in ocular hypertension (OHT) and primary open angle glaucoma (POAG)

ISRCTN ISRCTN66330584
DOI https://doi.org/10.1186/ISRCTN66330584
Secondary identifying numbers N0013184505
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
07/12/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Avinash A Kulkarni
Scientific

Lambeth Road
London
SE1 7EH
United Kingdom

Phone +44 (0)2071887188

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesAt the present time, although SLT is accepted as a viable treatment for OHT / POAG, there has not been a thorough assessment of the optimum Laser power settings which enable safe and effective treatment. This study aims to scientifically compare high power settings with low power settings, investigating the efficacy of treatment in lowering intraocular pressure during the follow-up period after treatment, and the incidence of adverse events related to Laser treatment. Secondary Research Objectives: None
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEye Diseases: Ocular hypertension (OHT)
InterventionResearch participants are to be recruited from the NHS glaucoma clinic at St. Thomas' Hospital over a 6 months period, starting 1st May 2004. Eligible participants will be patients with OHT or POAG, which is uncontrolled in one or both eyes despite maximal topical medical therapy. We aim to recruit 60 patients.

Each patient will be randomized to treatment with the Laserex Solo SLT Glaucoma Laser in one of three treatment groups:
Group 1 will receive high-energy SLT (1.2mJ shots) in one or both eyes
Group 2 will receive medium energy SLT (0.8mJ shots) in one or both eyes
Group 3 will receive low-energy SLT (0.4mJ shots) in one or both eyes.

The decision to treat either one or both eyes will depend on whether the intraocular pressure is too high in one or both eyes. Therefore only eyes with uncontrolled pressure will be treated. Some patients may have both eyes treated. In these cases data for the study will only be collected for one eye. Thus, in total, 20 patients will be allocated to each of the 3 groups with 20 eyes per group (one per patient).
Intervention typeOther
Primary outcome measure1. Visual field defect progression
2. Disc cup appearances
Secondary outcome measuresNot provided at time of registration
Overall study start date01/08/2005
Completion date01/08/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants40
Key inclusion criteriaPatients with OHT or POAG, which is uncontrolled despite maximal topical medical therapy.
Key exclusion criteriaPatients who do not meet inclusion criteria
Date of first enrolment01/08/2005
Date of final enrolment01/08/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Lambeth Road
London
SE1 7EH
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Guy's and St. Thomas' NHS Foundation Trust

No information available

Own account

No information available

NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2010 Yes No